Why Choose Onco360?

We Are The Oncology Pharmacy Experts

Onco360 is not a traditional specialty pharmacy that treats multiple disease states. We focus on one thing – oncology. It’s all we do. Patients will receive compassionate and personalized clinical support from our licensed Board-Certified Oncology Pharmacists, nurses, and specialists to carefully manage treatment from start to finish.

Onco360’s Mission, Vision, and Values

Onco360 - An Oncology Pharmacy with Heart

Mission

As a healthcare company dedicated to Oncology Pharmacy, Onco360 strives to improve the lives of patients battling cancer.

Onco360

Vision

Using our innovative, patient-centric approach, we help navigate the complexities of cancer care through:

  • Oncology clinical expertise
  • Timely & affordable access to care
  • Compassion
Onco360

Values

TEAMWORK – Collaborating to provide service excellence to our patients and healthcare providers.

RESPECT – Understanding patients are people first, and treating them with compassion and care.

INTEGRITY– Doing the right thing for all stakeholders guides our work.

PASSION – Supporting patients, caregivers and healthcare providers in their fight against cancer.

Our Commitment

We are dedicated to providing the best possible oncology pharmacy care to each and every patient entrusted to our service, and we have developed an oncology-specific pharmacy dispensing and clinical model that provides value-based solutions for patients, physicians, hospitals, payers, and manufacturers.

How We Help:

PATIENTS

How we partner with our provider offices to help patients

PHYSICIANS

We work closely with our pharma partners to provide best in class oncology care

PHARMA

How we work with our payer partners

PAYERS

How we work with our hospital systems

HOSPITALS

Onco360 started as a single-location oncology pharmacy in 2003 and is headquartered in Louisville, KY. We dispense nationally through our network of URAC-, ACHC-, and NABP Digital-accredited oncology pharmacies.

*Third party survey data provided by MMIT for Independent Specialty Pharmacies (Oncology). Report dates Q3 & Q4 2021.